Skip to main content

Circular Genomics

Albuquerque, United States

Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.

$8.3M raised
Jan 2024
Series A

Top Investors

Cottonwood Technology FundNew Mexico Economic Development DepartmentMountain Group CapitalTramway Venture PartnersUNM Rainforest Innovations

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Circular Genomics

How much funding has Circular Genomics raised?
Circular Genomics has raised $8.3M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
Who are Circular Genomics's investors?
Circular Genomics's investors include Cottonwood Technology Fund, New Mexico Economic Development Department, Mountain Group Capital, Tramway Venture Partners, UNM Rainforest Innovations.
Where is Circular Genomics headquartered?
Circular Genomics is headquartered in Albuquerque, United States.
What does Circular Genomics do?
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.
What stage is Circular Genomics at?
Circular Genomics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Circular Genomics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/circular-genomics. Accessed June 17, 2026.
APA
VCBacked. (2024). Circular Genomics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/circular-genomics
Wikipedia (cite web)
{{cite web |title=Circular Genomics — Funding & Investors |url=https://www.vcbacked.co/company/circular-genomics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .